Tuesday, 28 September, 2021

Australia raises age limit for AstraZeneca jab after blood clots death

AstraZeneca treatment unsuccessful at preventing symptomatic COVID-19 AstraZeneca’s antibody cocktail fails to protect against coronavirus: Study
Cecil Davis | 18 June, 2021, 00:39

However, the vaccine committee said evidence emerging from studies in Germany suggests mixing one dose of AstraZeneca with a second dose of a Pfizer vaccine can actually produce "a potentially better immune response, including against variants of concern" than two doses of AstraZeneca alone.

Health Minister Greg Hunt described the decision on Thursday as conservative and reflecting the relatively low risk of catching the virus in Australia. "The answer remains, in the advice we have, is yes".

About 25.5 per cent of the total population eligible for vaccination have received their jab, he added, but conceded the change to the advice would bring "some challenges".

"Discussions regarding next steps with the USA government are ongoing", the company said.

Previously, NACI had said AstraZeneca recipients could choose whether to get a second dose of the same vaccine, or an mRNA vaccine.

"I would strongly encourage everyone to get that full protection".

CDC now calls coronavirus Delta variant a 'variant of concern'
Another analysis of Delta variant was done in Scotland and published covered a period between April 6 and June 6. The Delta variant has been rapidly expanding throughout Canada.

"For most people, they've been diagnosed early, there was a large proportion of those with a less severe form of this of this rare syndrome, and most of those have been discharged from hospital already".

Prof Kelly added in a statement that for people over 60, "the benefits of vaccination, with any vaccine including AstraZeneca, far outweigh the risks". The country has seen 60 cases of blood clots, including two deaths, after administering 3.3 million doses of AstraZeneca vaccine, Reuters reported.

For people aged 50 to 59, the rate is 2.7 per 100,000 doses. There are now a total 37 confirmed and 23 probable cases of TTS in Australia. "Cases overseas have been reported at all ages".

However, Australians who have already received AstraZeneca are being told to continue to get their second shot. The first was a 48-year-old woman who died in April. The "mixed vaccine schedule" refers to the practice of using different products for the first and second doses.

NACI said provinces can easily shift to an mRNA-based immunization campaign because Canada is poised to receive a flood of shots from Pfizer and Moderna in the coming weeks, with 14 million more doses set to arrive this month.

"Australia does not have enough back up options and now we're paying the price with not enough supply".